ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 2887 for:    SUSTAIN 3

A Long-term Safety Study of Intranasal Esketamine in Treatment-resistant Depression (SUSTAIN-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02782104
Recruitment Status : Recruiting
First Posted : May 25, 2016
Last Update Posted : September 25, 2018
Sponsor:
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 6, 2021
  Estimated Study Completion Date : September 30, 2021